Dr. Robert Chen, PhD

Antibody Engineer at Chai Discovery

Speaker

Robert Chen is an Antibody Engineer at Chai Discovery, a de novo protein design startup, where he works across scientific partnerships and internal R&D. Previously, he was a Senior Scientist and early employee at Cartography Biosciences, developing therapeutics against novel cancer targets. He engineered the tumor-associated antigen arm of CBI-1214, Cartography’s LY6G6D×CD3 T-cell engager for colorectal cancer, and was a core contributor to the program from conception through clinical initiation. Robert earned his PhD in Bioengineering from Stanford University in Howard Chang’s lab, where he developed circular RNA technology that was spun out and ultimately acquired by Bristol Myers Squibb.